Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

25.04
+0.61002.50%
Post-market: 25.00-0.0400-0.16%16:37 EDT
Volume:276.27K
Turnover:6.83M
Market Cap:683.20M
PE:-146.44
High:25.07
Open:24.81
Low:24.33
Close:24.43
52wk High:27.29
52wk Low:13.09
Shares:27.28M
Float Shares:17.82M
Volume Ratio:0.58
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1710
EPS(LYR):-0.1710
ROE:-18.19%
ROA:3.59%
PB:26.12
PE(LYR):-146.44

Loading ...

Eton Pharmaceuticals Names Judith Matthews CFO

MT Newswires Live
·
Apr 16

Eton Pharma names Judy Matthews CFO, succeeding James Gruber

Reuters
·
Apr 16

Eton Pharmaceuticals Inc - Appoints Judith M. Matthews as CFO Effective June 1, 2026

THOMSON REUTERS
·
Apr 16

Eton Pharmaceuticals Inc - James Gruber to Step Down as CFO Effective May 31, 2026

THOMSON REUTERS
·
Apr 16

Press Release: Eton Pharmaceuticals Announces CFO Succession Plan

Dow Jones
·
Apr 16

Eton Pharma amends SWK credit agreement, cuts interest rate to SOFR+6.55%

Reuters
·
Apr 16

Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
Mar 21

Eton Pharmaceuticals price target raised to $35 from $30 at Craig-Hallum

TIPRANKS
·
Mar 20

B. Riley Raises Price Target on Eton Pharmaceuticals to $31 From $26, Keeps Buy Rating

MT Newswires Live
·
Mar 20

U.S. RESEARCH ROUNDUP-Air Products, Chevron, FedEx

Reuters
·
Mar 20

Eton Pharma Q4 product sales rise 83% to USD 21.3 million, adjusted gross profit more than doubled to USD 15.5 million

Reuters
·
Mar 20

BRIEF-Eton Pharmaceuticals Q4 Net Income USD 1.483 Million

Reuters
·
Mar 20

Eton Pharmaceuticals Q4 EPS USD 0.05

THOMSON REUTERS
·
Mar 20

Eton Pharmaceuticals Inc - Expects FY2026 Revenue to Exceed $110 Mln, Adj Ebitda Margin Over 30%

THOMSON REUTERS
·
Mar 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 16

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 13

Eton Pharmaceuticals Inc. to Report Fourth-Quarter and Full-Year Financial Results and Host Conference Call

Reuters
·
Mar 04

Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
Mar 03

Eton Pharmaceuticals Rises on Acquisition of Hemangeol U.S. Commercialization Rights

Dow Jones
·
Mar 03